查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379108

免疫調節劑市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Immunomodulators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球免疫調節劑市場規模達1,998億美元。展望未來， IMARC Group預計到2028年市場規模將達到2,787億美元，2022-2028年複合年成長率（CAGR）為5.7%。

免疫調節劑是一組用於改變針對傳染病、免疫缺陷和抗體轉移改變的免疫反應的藥物。這些藥物通常包括單株抗體、細胞激素、左旋咪唑和卡介苗（BCG）。它們廣泛用於治療癌症、氣喘、腫瘤、遺傳性血管性水腫和自體免疫疾病，如天皰瘡、紅斑性狼瘡、過敏和類風濕關節炎。如今，一些醫療保健提供者推薦免疫調節劑與其他藥物（例如生物製劑）一起用於治療發炎性腸道疾病（IBD）。

免疫調節劑市場趨勢：

由於快速城市化、收入水平上漲以及加工食品消費的增加，個人不健康的生活方式導致全球慢性病盛行率顯著上升。這進一步增加了對器官移植的需求，這對作為器官移植受者有前途的治療劑的局部免疫調節劑的需求產生了積極影響。此外，人口老化的加劇和事故數量的增加也增加了器官衰竭的風險。因此，一些管理和非管理當局正在鼓勵器官捐贈，這反過來又促進了全球局部免疫調節劑的銷售。除此之外，發炎性腸道疾病和自體免疫疾病的盛行率不斷上升也推動了市場的成長。免疫調節劑也用於聯合治療，以減少對類固醇的長期需求，防止復發，並治療對抗生素無反應的疾病。此外，包括氟伏沙明、托珠單抗和巴瑞替尼合併瑞德西韋在內的多種免疫調節劑正在用於治療冠狀病毒病 (COVID-19) 住院患者。除此之外，一些候選產品目前正處於後期臨床試驗階段。這些產品的開發預計將擴大免疫調節劑在治療各種危及生命的疾病方面的應用。

本報告回答的關鍵問題：

  • 迄今為止，全球免疫調節劑市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球免疫調節劑市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球免疫調節劑市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球免疫調節劑市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 免疫抑制劑
    • 市場走向
    • 關鍵環節
      • 抗體
      • 鈣調磷酸酶抑制劑
      • 糖皮質激素
      • 抗代謝藥
      • 其他
    • 市場預測
  • 免疫增強劑
    • 市場走向
    • 關鍵環節
      • 疫苗
      • 抗體
      • 其他
    • 市場預測

第 7 章：按應用分類的市場區隔

  • 腫瘤學
    • 市場走向
    • 市場預測
  • 呼吸系統
    • 市場走向
    • 市場預測
  • 愛滋病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amgen Inc.
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
Product Code: SR112023A4055

Abstract

The global immunomodulators market size reached US$ 199.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 278.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2022-2028.

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunomodulators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and application.

Breakup by Product:

Immunosuppressants

Antibodies

Calcineurin Inhibitors

Glucocorticoids

Antimetabolites

Others

Immunostimulants

Vaccines

Antibodies

Others

Breakup by Application:

Oncology

Respiratory

HIV

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Key Questions Answered in This Report:

  • How has the global immunomodulators market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunomodulators market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunomodulators market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunomodulators Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunosuppressants
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Antibodies
      • 6.1.2.2 Calcineurin Inhibitors
      • 6.1.2.3 Glucocorticoids
      • 6.1.2.4 Antimetabolites
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Immunostimulants
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Antibodies
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Respiratory
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 HIV
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biogen Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bristol-Myers Squibb Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Eli Lilly and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Johnson & Johnson
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Merck & Co. Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Pfizer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
  • Figure 2: Global: Immunomodulators Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: North America: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: United States: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Canada: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: China: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Japan: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: India: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Australia: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Others: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Europe: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Germany: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: France: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Italy: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Spain: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Russia: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Global: Immunomodulators Industry: SWOT Analysis
  • Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
  • Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Immunomodulators Market: Competitive Structure
  • Table 6: Global: Immunomodulators Market: Key Players